Literature DB >> 7810811

Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.

F O Ter Kuile1, P Teja-Isavatharm, M D Edstein, D Keeratithakul, G Dolan, F Nosten, L Phaipun, H K Webster, N J White.   

Abstract

Whole blood mefloquine, halofantrine, and desbutyl-halofantrine concentrations were measured by high-performance liquid chromatography in capillary blood, venous blood, and venous plasma samples from patients along the Thai/Burmese border with falciparum malaria who were treated with either mefloquine (25 mg/kg) or halofantrine (24 mg/kg or 72 mg/kg). The limits of detection for mefloquine, halofantrine, and desbutyl-halofantrine were 50, 15, and 10 ng/ml, respectively, with 200 microliters whole blood samples. There was a good linear correlation (r > 0.9) between capillary and venous blood and between whole blood and plasma for all three compounds. Mefloquine concentrations in venous and capillary blood were very similar (mean ratio 1.02, 95% confidence intervals [CI] 0.95-1.09, n = 60), but were 1.15 times higher (95% CI 1.03-1.29) in whole blood than in plasma (n = 22). The halofantrine and desbutyl-halofantrine concentrations were 1.27 (1.12-1.45, n = 23) and 1.34 (1.16-1.55, n = 24) times higher in venous compared to capillary blood, while halofantrine but not desbutyl-halofantrine concentrations were lower in whole blood than in plasma (mean ratios: halofantrine: 0.83 [0.72, 0.94], n = 39 and desbutyl-halofantrine: 1.05 [0.96-1.15], n = 41). Measurement of mefloquine, halofantrine, or desbutyl-halofantrine in capillary blood is an accurate and practical alternative to venous blood sampling, and is particularly useful for sampling with children, and under field conditions when technical facilities are limited.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810811     DOI: 10.4269/ajtmh.1994.51.778

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegårdh; Rose McGready; Robert Hutagalung; Rae Hae; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

Authors:  J A Simpson; E R Watkins; R N Price; L Aarons; D E Kyle; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.

Authors:  R Price; J A Simpson; P Teja-Isavatharm; M M Than; C Luxemburger; D G Heppner; T Chongsuphajaisiddhi; F Nosten; N J White
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.